| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Hyoscyamine sulfate |
Is a |
False |
Hyoscyamine (substance) |
Inferred relationship |
Some |
|
| Methscopolamine (substance) |
Is a |
False |
Hyoscyamine (substance) |
Inferred relationship |
Some |
|
| Hyoscyamine measurement |
Component |
True |
Hyoscyamine (substance) |
Inferred relationship |
Some |
1 |
| Accidental hyoscine poisoning |
Causative agent (attribute) |
False |
Hyoscyamine (substance) |
Inferred relationship |
Some |
|
| Intentional hyoscine poisoning |
Causative agent (attribute) |
False |
Hyoscyamine (substance) |
Inferred relationship |
Some |
|
| Hyoscine poisoning of undetermined intent |
Causative agent (attribute) |
False |
Hyoscyamine (substance) |
Inferred relationship |
Some |
|
| Hyoscine adverse reaction |
Causative agent (attribute) |
False |
Hyoscyamine (substance) |
Inferred relationship |
Some |
1 |
| Hyoscine hydrobromide adverse reaction |
Causative agent (attribute) |
False |
Hyoscyamine (substance) |
Inferred relationship |
Some |
|
| Allergy to hyoscine |
Causative agent (attribute) |
False |
Hyoscyamine (substance) |
Inferred relationship |
Some |
|
| Hyoscine hydrobromide allergy |
Causative agent (attribute) |
False |
Hyoscyamine (substance) |
Inferred relationship |
Some |
|
| Hyoscine overdose |
Causative agent (attribute) |
False |
Hyoscyamine (substance) |
Inferred relationship |
Some |
|
| Accidental hyoscine overdose |
Causative agent (attribute) |
False |
Hyoscyamine (substance) |
Inferred relationship |
Some |
|
| Intentional hyoscine overdose |
Causative agent (attribute) |
False |
Hyoscyamine (substance) |
Inferred relationship |
Some |
|
| Hyoscine overdose of undetermined intent |
Causative agent (attribute) |
False |
Hyoscyamine (substance) |
Inferred relationship |
Some |
|
| Product containing precisely hyoscyamine 150 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hyoscyamine (substance) |
Inferred relationship |
Some |
|
| Hyoscyamine hydrobromide (substance) |
Is a |
False |
Hyoscyamine (substance) |
Inferred relationship |
Some |
|
| Product containing hyoscyamine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hyoscyamine (substance) |
Inferred relationship |
Some |
1 |
| Hyoscyamine m/r |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hyoscyamine (substance) |
Inferred relationship |
Some |
|
| Hyoscyamine-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hyoscyamine (substance) |
Inferred relationship |
Some |
1 |
| Poisoning by hyoscine |
Causative agent (attribute) |
False |
Hyoscyamine (substance) |
Inferred relationship |
Some |
|
| Product containing hyoscyamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hyoscyamine (substance) |
Inferred relationship |
Some |
1 |
| Product containing hyoscyamine and phenazopyridine and secbutabarbital (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hyoscyamine (substance) |
Inferred relationship |
Some |
2 |
| Hyoscine butylbromide allergy |
Causative agent (attribute) |
False |
Hyoscyamine (substance) |
Inferred relationship |
Some |
|
| Intentional hyoscine poisoning |
Causative agent (attribute) |
False |
Hyoscyamine (substance) |
Inferred relationship |
Some |
|
| Allergy to hyoscine |
Causative agent (attribute) |
False |
Hyoscyamine (substance) |
Inferred relationship |
Some |
1 |
| Hyoscine butylbromide allergy |
Causative agent (attribute) |
False |
Hyoscyamine (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely hyoscyamine 150 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hyoscyamine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely hyoscyamine 150 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hyoscyamine (substance) |
Inferred relationship |
Some |
1 |
| Hyoscyamine sulfate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Hyoscyamine (substance) |
Inferred relationship |
Some |
|
| Hyoscyamine hydrobromide (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Hyoscyamine (substance) |
Inferred relationship |
Some |
|
| Product containing precisely hyoscyamine 150 microgram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hyoscyamine (substance) |
Inferred relationship |
Some |
1 |
| Atropine- and hyoscine- and hyoscyamine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hyoscyamine (substance) |
Inferred relationship |
Some |
1 |
| Product containing atropine and hyoscyamine and scopolamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hyoscyamine (substance) |
Inferred relationship |
Some |
1 |
| Product containing only atropine and hyoscyamine and scopolamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hyoscyamine (substance) |
Inferred relationship |
Some |
1 |
| Hyoscyamine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hyoscyamine (substance) |
Inferred relationship |
Some |
1 |
| Hyoscyamine and phenazopyridine and secbutabarbital only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hyoscyamine (substance) |
Inferred relationship |
Some |
2 |
| Atropine and hyoscine and hyoscyamine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hyoscyamine (substance) |
Inferred relationship |
Some |
1 |
| Product containing only hyoscyamine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hyoscyamine (substance) |
Inferred relationship |
Some |
1 |
| Product containing only hyoscyamine in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hyoscyamine (substance) |
Inferred relationship |
Some |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]